Literature DB >> 9558095

Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells.

D Gibellini1, A Bassini, S Pierpaoli, L Bertolaso, D Milani, S Capitani, M La Placa, G Zauli.   

Abstract

Extracellular HIV-1 Tat protein (0.1-100 ng/ml) induced a rapid (peak at 30 min) increase in the Ser133 phosphorylation levels of the transcription factor CREB in serum-starved Jurkat cells, as revealed by Western blot and indirect immunofluorescence analyses. Nuclear cAMP-responsive element (CRE) binding activity in electrophoretic mobility shift assays was constitutive in unstimulated Jurkat cells, showing only a small increase upon Tat treatment. However, transient transfection experiments performed with various chloramphenicol acetyl-transferase (CAT) constructs showed that Tat produced a fourfold induction of CAT activity only in the presence of a CRE-dependent CAT construct. Moreover, the use of plasmids encoding for GAL4-CREB fusion proteins demonstrated that Tat induction of pG4-CAT reporter gene required the CREB moiety of the GAL4-CREB fusion protein and that Ser133 CREB was essential for Tat activity. Extracellular Tat also stimulated Ser133 CREB phosphorylation in freshly isolated PBMC; this effect was completely blocked by either staurosporin, a broad-spectrum inhibitor of various protein kinases, or PD 98059, a specific inhibitor of mitogen-activated protein kinases (MAPK). Furthermore, extracellular Tat induced a rapid (peak at 5-15 min) stimulation of the MAPK catalytic activity in primary PBMC. Altogether, these findings suggest that HIV-1 Tat protein activates CREB in lymphoid cells through a signal cascade involving the MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558095

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine.

Authors:  R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein.

Authors:  D Gibellini; M C Re; F Vitone; N Rizzo; C Maldini; M La Placa; G Zauli
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

3.  The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL.

Authors:  Francesco Carinci; Lorenzo Monasta; Corrado Rubini; Daniela Stramazzotti; Annalisa Palmieri; Elisabetta Melloni; Alex Knowles; Luca Ronfani; Giorgio Zauli; Paola Secchiero
Journal:  Invest New Drugs       Date:  2010-11-18       Impact factor: 3.850

Review 4.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

5.  PKC alpha-mediated CREB activation is oxygen and age-dependent in rat myocardial tissue.

Authors:  Camillo Di Giulio; Monica Rapino; Maria Zingariello; Adriano Antonucci; Amelia Cataldi
Journal:  Histochem Cell Biol       Date:  2006-11-21       Impact factor: 4.304

6.  Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL.

Authors:  Arianna Gonelli; Oriano Radillo; Sara Drioli; Erika Rimondi; Paola Secchiero; Gian Maria Bonora
Journal:  Invest New Drugs       Date:  2010-12-02       Impact factor: 3.850

7.  The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status.

Authors:  Giorgio Zauli; Claudio Celeghini; Elisabetta Melloni; Rebecca Voltan; Manuele Ongari; Mario Tiribelli; Maria Grazia di Iasio; Francesco Lanza; Paola Secchiero
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

8.  Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication.

Authors:  P Secchiero; D Zella; S Curreli; P Mirandola; S Capitani; R C Gallo; G Zauli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

9.  SOCS1 is significantly up-regulated in Nutlin-3-treated p53wild-type B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155.

Authors:  Maria Grazia di Iasio; Alessia Norcio; Elisabetta Melloni; Giorgio Zauli
Journal:  Invest New Drugs       Date:  2012-01-13       Impact factor: 3.850

10.  The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts.

Authors:  Paola Secchiero; Carlotta Zerbinati; Elisabetta Melloni; Daniela Milani; Diana Campioni; Roberto Fadda; Mario Tiribelli; Giorgio Zauli
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.